DURHAM, N.C., May 02, 2017 -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company discovering, developing and commercializing medicines that improve outcomes for immunocompromised patients, today announced that it will host a live conference call and audio webcast on Tuesday, May 9, 2017 at 8:30 a.m. ET to report financial results for the first quarter ended March 31, 2017, and to provide a business overview.
To access the live conference call, please dial (877) 354-4056 (domestic) or (678) 809-1043 (international) at least five minutes prior to the start time, and refer to conference ID 3258363. A live audio webcast of the call will also be available on the Investors’ section of the Company's website, www.chimerix.com. An archived webcast will be available on the Chimerix website approximately two hours after the event.
About Chimerix
Chimerix is a biopharmaceutical company dedicated to discovering, developing and commercializing medicines that improve outcomes for immunocompromised patients. Chimerix's proprietary lipid conjugate technology has produced brincidofovir (BCV); CMX157, which was licensed to ContraVir Pharmaceuticals; and earlier-stage clinical candidates. Chimerix recently announced a new clinical candidate, CMX521, for the treatment and/or prevention of norovirus. For further information, please visit Chimerix's website, www.chimerix.com.
CONTACT: Investor Relations: [email protected] or Will O’Connor Stern Investor Relations [email protected] 212-362-1200 Media: Becky Vonsiatsky W2O Group [email protected] 413-478-2003


Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit
Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal
BitGo IPO Prices Above Range, Raises $212.8M in Landmark Crypto Market Debut
Apple Stock Jumps as Company Prepares Major Siri AI Chatbot Upgrade
Netflix Stock Slips After Earnings as Soft 2026 Guidance Overshadows Subscriber Milestone
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer
FAA Says It Is Not Blocking Boeing 737 MAX 7 and MAX 10 Certification
Lynas Rare Earths Shares Surge as Quarterly Revenue Jumps on Strong Prices
Rio Tinto Posts Strong Q4 Iron Ore and Copper Output on Operational Recovery
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks
Brazil Supreme Court Orders Asset Freeze of Nelson Tanure Amid Banco Master Investigation
Nvidia CEO Jensen Huang Plans China Visit Amid AI Chip Market Uncertainty
United Airlines Posts Record Q4 Revenue as Premium Demand Lifts Earnings
Valentino Garavani Dies at 93, Leaving Behind the Timeless Legacy of Valentino Red
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 



